Yongwei Jiang

435 total citations
33 papers, 337 citations indexed

About

Yongwei Jiang is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases and Surgery. According to data from OpenAlex, Yongwei Jiang has authored 33 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Infectious Diseases and 8 papers in Surgery. Recurrent topics in Yongwei Jiang's work include Diabetes Management and Research (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Yongwei Jiang is often cited by papers focused on Diabetes Management and Research (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Yongwei Jiang collaborates with scholars based in China, United States and Russia. Yongwei Jiang's co-authors include Liang Ma, Ping Li, Qian Liu, Xiaomu Kong, Tingting Zhao, Shiqing Xu, Hailing Zhao, Wenjian Zhang, Jinning Lou and Yuanying Jiang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Tetrahedron and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Yongwei Jiang

33 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongwei Jiang China 12 93 77 77 73 52 33 337
Eva Knuplez Austria 11 166 1.8× 65 0.8× 50 0.6× 23 0.3× 48 0.9× 14 395
Qianzhou Lv China 13 112 1.2× 40 0.5× 46 0.6× 21 0.3× 94 1.8× 41 428
Sonia Chew Wen Phang Malaysia 11 63 0.7× 22 0.3× 51 0.7× 15 0.2× 83 1.6× 15 499
Peifeng Ke China 11 108 1.2× 52 0.7× 61 0.8× 16 0.2× 56 1.1× 54 391
Aneta Bąk Poland 11 94 1.0× 17 0.2× 34 0.4× 16 0.2× 27 0.5× 27 383
Selver Özekinci Türkiye 10 36 0.4× 64 0.8× 36 0.5× 19 0.3× 51 1.0× 38 319
Bülent Şengül Türkiye 8 376 4.0× 76 1.0× 34 0.4× 27 0.4× 19 0.4× 15 486
Hongyang Liu China 14 189 2.0× 33 0.4× 17 0.2× 15 0.2× 87 1.7× 37 528
Mark Allison United States 9 171 1.8× 25 0.3× 36 0.5× 11 0.2× 81 1.6× 14 514

Countries citing papers authored by Yongwei Jiang

Since Specialization
Citations

This map shows the geographic impact of Yongwei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongwei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongwei Jiang more than expected).

Fields of papers citing papers by Yongwei Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongwei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongwei Jiang. The network helps show where Yongwei Jiang may publish in the future.

Co-authorship network of co-authors of Yongwei Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yongwei Jiang. A scholar is included among the top collaborators of Yongwei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongwei Jiang. Yongwei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Guo‐Xiong, et al.. (2025). Dynamic DNA methylation of EPHX2 in diabetic kidney disease progression: A potential biomarker. Gene Reports. 40. 102245–102245. 1 indexed citations
2.
Jiang, Yongwei, Xiaomu Kong, Mo Li, et al.. (2024). The Analysis of Plasma Proteomics for Luminal A Breast Cancer. Cancer Medicine. 13(23). e70470–e70470. 1 indexed citations
3.
Ma, Liang, et al.. (2024). Development of a Novel Multiplex PCR Method for the Rapid Detection of SARS-CoV-2, Influenza A Virus, and Influenza B Virus. International Journal of Analytical Chemistry. 2024. 1–9. 4 indexed citations
4.
Jiang, Yongwei, Guo‐Xiong Deng, Han Tang, et al.. (2024). Tangshen formula improves diabetic nephropathy in STZ-induced diabetes rats fed with hyper-methionine by regulating the methylation status of kidney. Clinical Epigenetics. 16(1). 1–1. 6 indexed citations
5.
Jiang, Yongwei, Qian Liu, Xiaomu Kong, et al.. (2023). Role of HLA class I and II alleles in susceptibility to ankylosing spondylitis in Chinese Han. Journal of Clinical Laboratory Analysis. 37(17-18). e24964–e24964. 2 indexed citations
7.
Ma, Liang, et al.. (2023). Fast and Sensitive Detection of SARS-CoV-2 Nucleic Acid Using a Rapid Detection System Free of RNA Extraction. International Journal of Analytical Chemistry. 2023. 1–10. 3 indexed citations
8.
Ma, Liang, Yongwei Jiang, Hui Yang, et al.. (2022). A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA. BMC Gastroenterology. 22(1). 191–191. 11 indexed citations
9.
Ma, Liang, Jian Gong, Xiaomu Kong, et al.. (2022). A Novel Stool Methylation Test for the Non-Invasive Screening of Gastric and Colorectal Cancer. Frontiers in Oncology. 12. 860701–860701. 12 indexed citations
10.
Ma, Liang, Shao‐Ting Wang, Hailing Zhao, et al.. (2021). Susceptibility of ApoB and PCSK9 Genetic Polymorphisms to Diabetic Kidney Disease Among Chinese Diabetic Patients. Frontiers in Medicine. 8. 659188–659188. 4 indexed citations
11.
Ma, Liang, Hailing Zhao, Tingting Zhao, et al.. (2020). Association of Epoxide Hydrolase 2 Gene Arg287Gln with the Risk for Primary Hypertension in Chinese. International Journal of Hypertension. 2020. 1–7. 8 indexed citations
12.
Liu, Yuanyuan, Liang Ma, Yongwei Jiang, et al.. (2019). Relationship between insertion/deletion polymorphism of angiotensin converting enzyme gene and type 2 diabetic kidney disease. Zhonghua jianyan yixue zazhi. 42(2). 116–122. 2 indexed citations
13.
Ma, Liang, Meihua Yan, Xiaomu Kong, et al.. (2018). Association of EPHX2 R287Q Polymorphism with Diabetic Nephropathy in Chinese Type 2 Diabetic Patients. Journal of Diabetes Research. 2018. 1–6. 10 indexed citations
14.
Ma, Liang, Yongwei Jiang, Xiaomu Kong, et al.. (2018). Interaction of MTHFR C677T polymorphism with smoking in susceptibility to diabetic nephropathy in Chinese men with type 2 diabetes. Journal of Human Genetics. 64(1). 23–28. 14 indexed citations
15.
Jiang, Yongwei, Wenjian Zhang, Shiqing Xu, et al.. (2017). Transplantation of human fetal pancreatic progenitor cells ameliorates renal injury in streptozotocin-induced diabetic nephropathy. Journal of Translational Medicine. 15(1). 147–147. 10 indexed citations
16.
Xu, Shiqing, Yongwei Jiang, Hui Wang, et al.. (2015). C-peptide ameliorates renal injury in type 2 diabetic rats through protein kinase A-mediated inhibition of fibronectin synthesis. Biochemical and Biophysical Research Communications. 458(3). 674–680. 12 indexed citations
17.
Xu, Shiqing, et al.. (2013). Gliquidone decreases urinary protein by promoting tubular reabsorption in diabetic Goto-Kakizaki rats. Journal of Endocrinology. 220(2). 129–141. 10 indexed citations
18.
Chai, Xiaoyun, Shichong Yu, Yongwei Jiang, et al.. (2012). Design, synthesis, and biological evaluation of novel 1, 2, 4-triazole derivatives as antifungal agent. Archives of Pharmacal Research. 35(11). 1895–1901. 7 indexed citations
19.
Wang, Hui, Wenjian Zhang, Cai H, et al.. (2011). α-cell loss from islet impairs its insulin secretion in vitro and in vivo. Islets. 3(2). 58–65. 3 indexed citations
20.
Jiang, Yongwei, Jun Zhang, Yongbing Cao, et al.. (2011). Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents. Bioorganic & Medicinal Chemistry Letters. 21(15). 4471–4475. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026